Locust Walk Acquisition announced the completion of its IPO of 17.5 million units at a price of $10 each, including 2.2 million units issued pursuant to the exercise of the underwriters’ over-allotment option.
The SPAC is focusing on the healthcare sector or healthcare-related industries in the United States and Europe, especially companies in the life sciences sector. Read more.
